Cognoa

Cognoa is a pioneering company in the field of early childhood development and pediatric behavioral health.

Headquarters

Year Founded

Search Tags

AI in Healthcare, Early Autism Diagnosis, Digital Health Solutions

About Us

Cognoa is a healthcare technology company focused on improving early diagnosis and intervention for children with developmental conditions, particularly autism. The company has developed Canvas Dx, an FDA-authorized diagnostic tool that enables clinicians to diagnose or rule out autism in children aged 1.5 to 6 years within days, significantly faster than traditional methods.

Trending Companies in AI

Latest Articles in AI

Medicare will pilot AI-driven prior authorization in 2026 across six states, targeting high-risk services while clinicians make final decisions.

AI-Powered Prior Authorization Comes to Traditional Medicare

Traditional Medicare will pilot AI-assisted prior authorization in 2026 across six states, focusing on high-risk outpatient services. Clinicians retain final say, but incentives and access concerns loom as CMS tests fraud reduction and “gold card” exemptions. Here’s what providers and patients should know.

Read More >